Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-28

FDA Approved: LAMOTRIGINE — Supplemental Application (Dr. Reddys Laboratories Inc.)

View source ↗

Summary

FDA approved a supplemental application for lamotrigine from Dr. Reddy's Laboratories Inc., under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)